These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 8519282

  • 1. Calcium entry blocking activities of MPC-1304 and of its enantiomers and metabolites.
    Okumura K, Ichihara K, Nagasaka M, Oda N, Tajima K.
    Eur J Pharmacol; 1993 Apr 22; 235(1):69-74. PubMed ID: 8519282
    [Abstract] [Full Text] [Related]

  • 2. Differential properties of the optical-isomers of pranidipine, a 1,4-dihydropyridine calcium channel modulator.
    Hirano T, Mori T, Kido M, Toide K, Ohura M, Fujiki H, Orito K, Yoshida K, Ikezono K, Sumida T, Nakayama N, Yabuuchi Y.
    Fundam Clin Pharmacol; 1999 Apr 22; 13(6):650-5. PubMed ID: 10626752
    [Abstract] [Full Text] [Related]

  • 3. Effect of the new calcium antagonist lercanidipine and its enantiomers on the migration and proliferation of arterial myocytes.
    Corsini A, Bonfatti M, Quarato P, Accomazzo MR, Raiteri M, Sartani A, Testa R, Nicosia S, Paoletti R, Fumagalli R.
    J Cardiovasc Pharmacol; 1996 Nov 22; 28(5):687-94. PubMed ID: 8945683
    [Abstract] [Full Text] [Related]

  • 4. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
    Kanda A, Haruno A, Miyake H, Nagasaka M.
    J Cardiovasc Pharmacol; 1992 Nov 22; 20(5):723-30. PubMed ID: 1280733
    [Abstract] [Full Text] [Related]

  • 5. Antihypertensive activity of OPC-13340, a new potent and long-acting dihydropyridine calcium antagonist, in rats.
    Nakayama N, Ikezono K, Mori T, Yamashita S, Nakayama S, Tanaka Y, Hosokawa T, Minami Y, Masutani K, Yamamura Y.
    J Cardiovasc Pharmacol; 1990 May 22; 15(5):836-44. PubMed ID: 1692946
    [Abstract] [Full Text] [Related]

  • 6. MPC-1304, another type of dihydropyridine, possessing highly potent vasodilating action.
    Miyoshi K, Kanda A, Miyake H, Ichihara K, Kamei H, Nagasaka M.
    Eur J Pharmacol; 1993 Jul 20; 238(2-3):139-48. PubMed ID: 7691619
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent.
    Asano M, Uchida W, Shibasaki K, Terai M, Inagaki O, Takenaka T, Matsumoto Y, Fujikura T.
    J Pharmacol Exp Ther; 1990 Jul 20; 254(1):204-11. PubMed ID: 1973196
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lacidipine: a calcium antagonist with potent and long-lasting antihypertensive effects in animal studies.
    Micheli D, Collodel A, Semeraro C, Gaviraghi G, Carpi C.
    J Cardiovasc Pharmacol; 1990 Apr 20; 15(4):666-75. PubMed ID: 1691398
    [Abstract] [Full Text] [Related]

  • 12. Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker.
    Oizumi K, Nishino H, Koike H, Sada T, Miyamoto M, Kimura T.
    Jpn J Pharmacol; 1989 Sep 20; 51(1):57-64. PubMed ID: 2810942
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increased calcium sensitivity in isolated resistance arteries from spontaneously hypertensive rats: effects of dihydropyridines.
    Boonen HC, De Mey JG.
    Eur J Pharmacol; 1990 Apr 25; 179(3):403-12. PubMed ID: 1694767
    [Abstract] [Full Text] [Related]

  • 16. Receptor occupation and pharmacokinetics of MPC-1304, a new Ca2+ channel antagonist, in spontaneously hypertensive rats.
    Nozawa Y, Miyake H, Yamada S, Uchida S, Ohkura T, Kimura R.
    Eur J Pharmacol; 1995 Dec 12; 287(2):191-6. PubMed ID: 8749035
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L, Angelico P, Ibba M, Poggesi E, Taddei C, Leonardi A, Testa R.
    Arzneimittelforschung; 1996 Jan 12; 46(1):15-24. PubMed ID: 8821512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.